229 related articles for article (PubMed ID: 2657746)
1. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
Siegall CB; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.
Siegall CB; Xu YH; Chaudhary VK; Adhya S; Fitzgerald D; Pastan I
FASEB J; 1989 Dec; 3(14):2647-52. PubMed ID: 2556314
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
Gawlak SL; Pastan I; Siegall CB
Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
[TBL] [Abstract][Full Text] [Related]
6. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes.
Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H
Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
[TBL] [Abstract][Full Text] [Related]
8. Barnase toxin: a new chimeric toxin composed of pseudomonas exotoxin A and barnase.
Prior TI; FitzGerald DJ; Pastan I
Cell; 1991 Mar; 64(5):1017-23. PubMed ID: 1900455
[TBL] [Abstract][Full Text] [Related]
9. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis.
Roberge FG; Lorberboum-Galski H; Le Hoang P; de Smet M; Chan CC; Fitzgerald D; Pastan I
J Immunol; 1989 Dec; 143(11):3498-502. PubMed ID: 2511243
[TBL] [Abstract][Full Text] [Related]
10. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
[TBL] [Abstract][Full Text] [Related]
11. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells.
Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I
J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522
[TBL] [Abstract][Full Text] [Related]
12. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.
Kunwar S; Pai LH; Pastan I
J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018
[TBL] [Abstract][Full Text] [Related]
14. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
Kihara A; Pastan I
Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
[TBL] [Abstract][Full Text] [Related]
15. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
[TBL] [Abstract][Full Text] [Related]
16. Cardiac allograft survival in mice treated with IL-2-PE40.
Lorberboum-Galski H; Barrett LV; Kirkman RL; Ogata M; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1008-12. PubMed ID: 2644640
[TBL] [Abstract][Full Text] [Related]
17. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
[TBL] [Abstract][Full Text] [Related]
18. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin.
Prior TI; Helman LJ; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jan; 51(1):174-80. PubMed ID: 1846308
[TBL] [Abstract][Full Text] [Related]
20. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
